Press Releases

Date Title and Summary
Toggle Summary Accuray Radixact® System with Synchrony® Technology Delivers Advanced Cancer Treatments at Multiple Hospitals in Japan
- First lung case in ASIA, and the first liver case in the world, were treated at Takarazuka City Hospital, Hyogo, Japan   - Japanese Red Cross Nagoya Daini Hospital, Aichi, and Kishiwada Tokushukai Hospital, Osaka, Japan, have started treating lung cases SUNNYVALE, Calif. , Sept.
Toggle Summary Accuray to Present at Lake Street Capital Markets' 4th Annual Best Ideas Growth Conference
Virtual event to take place on September 17, 2020 SUNNYVALE, Calif. , Sept. 10, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that Joshua H. Levine , president and chief executive officer and Shig Hamamatsu , chief financial officer will present at the fourth annual Lake
Toggle Summary University Hospital Città della Salute e della Scienza, Turin, Italy is First in EIMEA to Treat Cancer Patients Using the Accuray Radixact® System with Synchrony® Technology
Renowned Hospital in Turin, Italy Uses Innovative Radiation Therapy Delivery System to Expand Options for Advanced Cancer Care to More Patients SUNNYVALE, Calif. , Sept. 1, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the medical care team at University Hospital
Toggle Summary Accuray Reports Fourth Quarter and Fiscal 2020 Financial Results
SUNNYVALE, Calif. , Aug. 13, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2020 .     Q4 Fiscal 2020 and Recent Operating Highlights Gross orders of $94.3 million , including 8 orders from China Net
Toggle Summary Anne B. Le Grand Joins Accuray Board of Directors
SUNNYVALE, Calif. , July 22, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Anne B. Le Grand to the company's Board of Directors, effective as of July 16, 2020 . In addition, she will serve on the Board's Nominating and Corporate Governance Committee .
Toggle Summary Accuray To Report Fiscal Year-end 2020 Financial Results on August 13, 2020
SUNNYVALE, Calif. , July 16, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter and the 2020 fiscal year, ended June 30, 2020 after the market close on Thursday, August 13, 2020 . Management will host a conference call to review the
Toggle Summary Accuray Launches New CyberKnife® S7™ System
Geisinger Wyoming Valley Medical Center is First in the World to Treat Patients with the New System SUNNYVALE, Calif. , June 17, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today the company has launched the CyberKnife ® S7™ System , an innovative device combining speed,
Toggle Summary Accuray Synchrony® Real-time Adaptive Technology for the Radixact® System Wins 2020 MedTech Breakthrough Award
Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies SUNNYVALE, Calif. , May 19, 2020 /PRNewswire/ --  Accuray Incorporated  (NASDAQ: ARAY) today announced that MedTech Breakthrough , an independent market intelligence organization that recognizes the top
Toggle Summary Accuray Reports Fiscal 2020 Third Quarter Financial Results
SUNNYVALE, Calif. , April 28, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the third quarter of fiscal 2020 ended March 31, 2020 . Recent Company Highlights Gross orders increased 27% year-over-year to $106.0 million , including 11 orders from
Toggle Summary Accuray To Report Fiscal 2020 Third Quarter Financial Results on April 28, 2020
SUNNYVALE, Calif. , April 16, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) will report results for its third quarter ended March 31, 2020 on Tuesday, April 28, 2020 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m.

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.